The Supreme Court rejected a lawsuit challenging the Food and Drug Administration’s approach to regulating the abortion pill mifepristone with a ruling that will continue to allow the pills to be mailed to patients without an in-person doctor’s visit. Dr. Chris T. Pernell, Regent-At-Large at the American College of Preventative Medicine, joins Jim Acosta and panel to react.Â
Read the full article here












